Viewing Study NCT06388369


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2025-12-25 @ 8:28 PM
Study NCT ID: NCT06388369
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-29
First Post: 2024-04-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
Sponsor: University Hospital, Essen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module